Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes - PubMed

Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes

D Argaud et al. Eur J Biochem. 1993.

Free article

Abstract

Metformin (dimethylbiguanide) has been used for more than 30 years as an antihyperglycemic agent in the treatment of diabetes mellitus, but its effect on gluconeogenesis is still controversial. In isolated hepatocytes from fasted rats, a significant inhibition of glucose production from lactate/pyruvate (10:1, mol/mol), fructose, alanine or glutamine, following metformin addition, is observed. Moreover, in hepatocytes perifused with dihydroxyacetone as the gluconeogenic substrate and treated with 0.5 mM metformin, an inhibition of the glucose flux and a simultaneous stimulation of the lactate/pyruvate flux were observed. This enhancement of lactate/pyruvate formation appears to be due to an effect on the pyruvate-kinase enzyme. A direct effect of metformin on pyruvate kinase cannot explain this result, since pyruvate-kinase activity was not affected by metformin at this concentration. In contrast, the addition of metformin caused a significant decrease in the cellular ATP concentration, a known allosteric inhibitor of this enzyme. This could explain the stimulation of pyruvate-kinase activity following metformin addition and thus the inhibition of gluconeogenesis.

Similar articles

• Molecular action of metformin in hepatocytes: an updated insight.

  Sliwinska A, Drzewoski J. Sliwinska A, et al. Curr Diabetes Rev. 2015;11(3):175-81. doi: 10.2174/1573399811666150325233108. Curr Diabetes Rev. 2015. PMID: 25808533 Review.

Cited by

• Effects of glycemic control on glucose utilization and mitochondrial respiration during resuscitated murine septic shock.

  Vogt JA, Wachter U, Wagner K, Calzia E, Gröger M, Weber S, Stahl B, Georgieff M, Asfar P, Fontaine E, Radermacher P, Leverve XM, Wagner F. Vogt JA, et al. Intensive Care Med Exp. 2014 Dec;2(1):19. doi: 10.1186/2197-425X-2-19. Epub 2014 Jun 3. Intensive Care Med Exp. 2014. PMID: 26266919 Free PMC article.

• The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.

  Wiernsperger NF, Bailey CJ. Wiernsperger NF, et al. Drugs. 1999;58 Suppl 1:31-9; discussion 75-82. doi: 10.2165/00003495-199958001-00009. Drugs. 1999. PMID: 10576523 Review.

• Quantitative analysis of some mechanisms affecting the yield of oxidative phosphorylation: dependence upon both fluxes and forces.

  Rigoulet M, Leverve X, Fontaine E, Ouhabi R, Guérin B. Rigoulet M, et al. Mol Cell Biochem. 1998 Jul;184(1-2):35-52. Mol Cell Biochem. 1998. PMID: 9746311

• Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner.

  Wessels B, Ciapaite J, van den Broek NM, Nicolay K, Prompers JJ. Wessels B, et al. PLoS One. 2014 Jun 20;9(6):e100525. doi: 10.1371/journal.pone.0100525. eCollection 2014. PLoS One. 2014. PMID: 24950069 Free PMC article.

• Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions.

  Apostolova N, Iannantuoni F, Gruevska A, Muntane J, Rocha M, Victor VM. Apostolova N, et al. Redox Biol. 2020 Jul;34:101517. doi: 10.1016/j.redox.2020.101517. Epub 2020 May 25. Redox Biol. 2020. PMID: 32535544 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database